MRPL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.911200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.586200E-01
Normal-vs-Stage2
8.375600E-01
Normal-vs-Stage3
6.665200E-01
Normal-vs-Stage4
6.561200E-01
Stage1-vs-Stage2
7.168600E-01
Stage1-vs-Stage3
5.507400E-01
Stage1-vs-Stage4
5.790600E-01
Stage2-vs-Stage3
5.443800E-01
Stage2-vs-Stage4
2.348600E-01
Stage3-vs-Stage4
4.420000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.183800E-01
Normal-vs-AfricanAmerican
8.840400E-01
Normal-vs-Asian
4.915600E-01
Caucasian-vs-AfricanAmerican
9.973600E-01
Caucasian-vs-Asian
2.993000E-01
AfricanAmerican-vs-Asian
4.221800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.218200E-01
Normal-vs-Female
9.941000E-01
Male-vs-Female
3.970600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.271430E-01
Normal-vs-Age(41-60Yrs)
9.025800E-01
Normal-vs-Age(61-80Yrs)
8.453800E-01
Normal-vs-Age(81-100Yrs)
3.649600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.365300E-04
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.974200E-04
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.094300E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.614400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.606200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.659700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.779600E-01
Normal-vs-Daily Drinker
9.373200E-01
Normal-vs-Weekly Drinker
5.273800E-01
Normal-vs-Occasional Drinker
6.808400E-01
Normal-vs-Social Drinker
6.771600E-01
Non Drinker-vs-Daily Drinker
4.610400E-01
Non Drinker-vs-Weekly Drinker
7.613600E-01
Non Drinker-vs-Occasional Drinker
1.035580E-01
Non Drinker-vs-Social Drinker
8.727600E-01
Daily Drinker-vs-Weekly Drinker
3.417000E-01
Daily Drinker-vs-Occasional Drinker
3.474800E-01
Daily Drinker-vs-Social Drinker
5.948600E-01
Weekly Drinker-vs-Occasional Drinker
8.282400E-02
Weekly Drinker-vs-Social Drinker
6.407400E-01
Occasional Drinker-vs-Social Drinker
1.576850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.069000E-01
Normal-vs-Grade 2
6.095000E-01
Normal-vs-Grade 3
8.729900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.261000E-01
Grade 1-vs-Grade 3
1.235980E-01
Grade 1-vs-Grade 4
2.069000E-01
Grade 2-vs-Grade 3
9.640100E-02
Grade 2-vs-Grade 4
6.095000E-01
Grade 3-vs-Grade 4
8.729900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.046400E-01
Normal-vs-NonDiabetic
8.964800E-01
Diabetic-vs-NonDiabetic
4.041000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.980800E-01
Normal-vs-NoPancreatitis
8.613400E-01
Pancreatitis-vs-NoPancreatitis
9.827600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.586200E-01
Normal-vs-N1
7.957800E-01
N0-vs-N1
5.534400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.677800E-01
Normal-vs-TP53-NonMutant
9.701600E-01
TP53-Mutant-vs-TP53-NonMutant
1.189640E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
